This was the stock's second consecutive day of gains.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

Humacyte markets Symvess for the treatment of extremity vascular trauma. Read why HUMA stock is a Sell but can see its ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the senior health, home health & ...

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

The bill seeks to extend tax breaks, set during Trump’s first term in 2017 and on track to expire at the end of 2025, for ...